Unknown

Dataset Information

0

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination.

ABSTRACT:

SUBMITTER: Normark J 

PROVIDER: S-EPMC8314734 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.
| S-EPMC8926322 | biostudies-literature
Unknown Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.
| S-EPMC8440177 | biostudies-literature
Unknown Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination with a twelve-week interval.
| S-EPMC9385402 | biostudies-literature
Unknown Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19-BNT162b2 mRNA Vaccination.
| S-EPMC9316698 | biostudies-literature
Unknown Comparative immunogenicity and reactogenicity of heterologous ChAdOx1-nCoV-19-priming and BNT162b2 or mRNA-1273-boosting with homologous COVID-19 vaccine regimens.
| S-EPMC9366133 | biostudies-literature
Unknown Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
| S-EPMC8939765 | biostudies-literature
Unknown Neutralization of SARS-CoV-2 Omicron BA.1, BA.4, and BA.5 by primary ChAdOx1 nCoV-19, mRNA-1273, MVC-COV1901 and booster mRNA-1273 vaccination.
| S-EPMC9483497 | biostudies-literature
Unknown Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study.
| S-EPMC8520818 | biostudies-literature
Unknown Comparison of Humoral Antibody Responses and Seroconversion Rates between Two Homologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination in Patients Undergoing Maintenance Hemodialysis.
| S-EPMC10383458 | biostudies-literature
Unknown Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
| S-EPMC8095372 | biostudies-literature